menu search

Groundbreaking study reveals link between air pollution and incidence of parkinson’s disease

Phoenix, Oct. 31, 2023 (GLOBE NEWSWIRE) — A new study led by researchers at Barrow neurological Insti...

October 31, 2023, 10:07 pm

Functional electrical stimulation market anticipated to attain a valuation of us$ 931.4 million, with a 4.1% cagr by 2033 | future market insights, inc.

Functional Electrical Stimulation Industry Creates Waves in Muscle Strengthening Therapies. Functional Electrical Stimulation Market to Develop at a C...

October 25, 2023, 1:30 am

Neuroone® to present at the thinkequity conference on october 19, 2023

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”)...

October 13, 2023, 1:30 pm

Integra lifesciences holdings corporation (iart) shareholders should contact robbins llp for information about the class action allegations against integra lifesciences holdings corporation

SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entiti...

October 4, 2023, 10:31 pm

Karuna therapeutics to present data from the emergent program evaluating karxt in schizophrenia at the 36th european college of neuropsychopharmacology (ecnp) congress

BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative...

October 4, 2023, 6:30 am

Regeneron, intellia therapeutics expand research collaboration to make gene editing therapies

Regeneron Pharmaceuticals and Intellia Therapeutics have expanded their research collaboration to develop additional CRISPR-based gene editing therapi...

October 3, 2023, 7:10 am

Iart stock news: shareholders with large losses should contact robbins llp for information about integra lifesciences holdings corporation class action

SAN DIEGO, Sept. 27, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entit...

September 27, 2023, 5:25 pm

Harmony biosciences to participate in 2023 cantor global healthcare conference

PLYMOUTH MEETING, Pa. , Sept. 13, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutica...

September 13, 2023, 8:05 am

Globally recognized expert in rare neurologic diseases, dr. michael levy, joins trethera scientific advisory board

LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) — Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs ...

September 5, 2023, 2:55 pm

Pepgen announces presentations at the 2023 myotonic dystrophy foundation annual conference, ottawa neuromuscular disease meeting, and h.c. wainwright 25th annual global investment conference

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu...

September 1, 2023, 8:00 am

Karuna's robust liquidity paves way for karxt milestones (rating upgrade)

Karuna Therapeutics develops innovative treatments for psychiatric and neurological disorders, with the...

August 16, 2023, 5:08 pm

Why shares of design therapeutics are plummeting on tuesday

Design focuses on therapies to treat neurological disorders. The company said it has enough cash to fun...

August 15, 2023, 3:02 pm

Aruna bio announces oral presentation on treatment opportunities of lead program, ab126 at the exosome based therapeutic development summit and applications of exosomes bioprocess international confer

– AB126 is an unmodified exosome derived from neural stem cells with the innate ability to cross the blood-brain-barrier and provide potential thera...

August 15, 2023, 12:00 pm

Why is zynerba pharmaceuticals (zyne) stock up 270% today?

In a stunning turn of the tables, beleaguered cannabinoid therapeutics developer Zynerba Pharmaceuticals (NASDAQ: ZYNE ) skyrocketed on Monday followi...

August 14, 2023, 1:52 pm

Harmony biosciences to buy zynerba pharmaceuticals for up to $200 million

Shares of Zynerba Pharmaceuticals Inc. ZYNE, +0.89% jumped 300% premarket on Monday after Harmony Biosciences Holdings Inc. HRMY, -0.47% said it would...

August 14, 2023, 9:18 am

Capitalizing on inflammation's role in neurological disease part 1: coya therapeutics

Coya Therapeutics is developing Treg-enhancing therapeutics to target diseases driven by inflammation, including in the central nervous system, includ...

August 14, 2023, 5:45 am

Rising global uti cases and multidrug-resistant bacteria: fueling the urinary tract infection testing market to us$ 1.1 billion by 2033 | future market insights

Urinary tract infection (UTI) is a widespread infectious disease caused by bacteria, particularly complicated UTI (cUTI) due to urinary system abnorma...

August 4, 2023, 12:30 am

Barrow neurological foundation announces 2023 neuro night to raise funds for brain & spine research

Tickets are now available for the star-studded philanthropic event on October 27 PHOENIX, July 31, 2023 (GLOBE NEWSWIRE) — Neuro Night, Barrow ...

August 1, 2023, 12:05 am

Rewalk robotics announces planned changes to board of directors

Number of Director Seats to be Reduced to Eight from Ten MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 28, 2023 (GLOBE NEWSWIRE) — ReWalk Robot...

July 28, 2023, 8:15 pm

Biogen agrees to acquire reata pharmaceuticals for $7.3 billion in cash

Biogen Inc. BIIB, -0.93% said Friday it has agreed to acquire Reata Pharmaceuticals Inc. RETA, +2.32% for $7.3 billion in cash. Reata “has made sign...

July 28, 2023, 7:16 am


Search within

Pages Search Results: